Search results for: order for illumina ngs

NOVASEQ 6000 HIGH THROUGHPUT NEXT-GENERATION SEQUENCING (NGS) SYSTEM Solicitation ID/Procurement Identifier: FDA_192331210758 Ultimate Completion Date: Sat Aug 31 17:00:00 GMT 2024

Notice of Intent to Sole SourceNaval Medical Center San Diego (NMCSD) intends to award a sole source purchase order under the authority of FAR 13.106-1(b), due to only one source being available to meet the Government's needs, to Karius, Inc. at 975 Island DR Ste. 100 Redwood City, CA 94065-5173. Reference number is N0025919N0007.

Illumina - HiSeq X - PE 150 Cycle- Read length: 2 x 150 (Paired End) - Allocation: 56 lane(s) - Number of samples: 40 - Guaranteed output per sample: 140600 Mb - Guaranteed number of pass filter paired-end reads per sample: 933 million paired-end reads (466M reads in each direction) QC included (Qubit, Tapestation, qPCR) Sequencing Only Library PreparationLibrary type: Illumina - DNA (whole genome) - Number of libraries: 40 - Library prep kit: Kapa

NHLBI SEQUENCING CORE FACILITY REQUIRES ILLUMINA KITS AND REAGENTS IN ORDER TO CARRY OUT NEXT-GENERATION SEQUENCING ON ILLUMINA INSTRUMENTS FOR SUPPORTED INVESTIGATORS. Solicitation ID/Procurement Identifier: 75N92020D00022 Ultimate Completion Date: Tue Sep 02 17:00:00 GMT 2025

ILLUMINA INC:1107104 [20-003190] - TO PREPARE LIBRARIES FOR NEXT-GENERATION SEQUENCING OF 1056 PATIENT SAMPLES WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) TO PREPARE LIBRARIES FOR NEXT-GENERATION SEQUENCI... Solicitation ID/Procurement Identifier: 75N92020D00022 Ultimate Completion Date: Tue Sep 02 17:00:00 GMT 2025

Because these tasks are undertaken daily in research laboratories, there has been an increasing demand for NGS services of FBR.

will allow GEN to process single and paired-end read data from Illumina-compatible libraries, and requires flexibility of flowcell selection to include flowcells that range from 100 million to at least 1 billion single-end reads in a single run.

Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. Capability statements are due by 1:00 PM Local Time, August 24, 2020.

The sequencing reads will be evaluated for quality and subject to bioinformatic analysis in order to identify the sample contents at the strain level. *See attached Statement of Work for additional information* (vii) Performance location: USDA, ARS, NEA, DFFRU, 600 East Mermaid Lane, Wyndmoor, PA 19038. (viii) Provision at 52.212-1, Instructions to Offerors-Commercial, applies to this acquisition.